Cost-effectiveness and public health impact of RTS,S/AS01E malaria vaccine in Malawi, using a Markov static model [version 2; peer review: 2 approved]

Cost-effectiveness and public health impact of RTS,S/AS01E malaria vaccine in Malawi, using a Markov static model [version 2; peer review: 2 approved]

Background: The RTS,S/AS01E malaria vaccine is being assessed in Malawi, Ghana and Kenya as part of a large-scale pilot implementation programme. Even if impactful, its incorporation into immunisation programmes will depend on demonstrating cost-effectiveness. We analysed the cost-effectiveness and...

Full description

Bibliographic Details
Main Authors:	Latif Ndeketa, Donnie Mategula, Dianne J. Terlouw, Naor Bar-Zeev, Christophe J. Sauboin, Sophie Biernaux
Format:	Article
Language:	English
Published:	Wellcome 2021-08-01
Series:	Wellcome Open Research
Online Access:	https://wellcomeopenresearch.org/articles/5-260/v2

Similar Items

Geostatistical analysis of Malawi’s changing malaria transmission from 2010 to 2017 [version 2; peer review: 1 approved, 2 approved with reservations]
by: Michael Give Chipeta, et al.
Published: (2019-07-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
by: Griffin J. Bell, et al.
Published: (2020-06-01)

RTS,S/AS01 vaccine (Mosquirix™): an overview
by: Matthew B. Laurens
Published: (2020-03-01)

Malaria Burden Stratification in Malawi- A report of a consultative workshop to inform the 2023-2030 Malawi Malaria Strategic Plan [version 1; peer review: 1 approved, 2 approved with reservations]
by: Atupele Kapito-Tembo, et al.
Published: (2023-04-01)

RTS,S/AS01 malaria vaccine in African children.
by: Hill, A
Published: (2012)

Unravelling the impact of insecticide-treated bed nets on childhood malaria in Malawi
by: Julie-Anne A. Tangena, et al.
Published: (2023-01-01)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
by: Mark E Polhemus, et al.
Published: (2009-07-01)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
by: Aroosa Younis Nadeem, et al.
Published: (2022-04-01)

Care-seeking patterns amongst suspected paediatric pneumonia deaths in rural Malawi [version 1; peer review: 2 approved]
by: Carina King, et al.
Published: (2020-12-01)

RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi
by: Larry Han, et al.
Published: (2017-08-01)

Two decades of malaria control in Malawi: Geostatistical Analysis of the changing malaria prevalence from 2000-2022 [version 2; peer review: 1 approved, 3 approved with reservations]
by: Tapiwa Ntwere, et al.
Published: (2024-01-01)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
by: Bejon, P, et al.
Published: (2009)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
by: Gosling, R, et al.
Published: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
by: Roly Gosling, et al.
Published: (2016-04-01)

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up
by: Nicolas Praet, et al.
Published: (2022-04-01)

Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi
by: Sundos Khan, et al.
Published: (2020-02-01)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
by: Corinne S. Merle, et al.
Published: (2023-08-01)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
by: Hassan Mumtaz, et al.
Published: (2023-06-01)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
by: Seth Owusu-Agyei, et al.
Published: (2010-01-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
by: John N Waitumbi, et al.
Published: (2009-11-01)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
by: Daniel Ansong, et al.
Published: (2011-04-01)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
by: Olotu, A, et al.
Published: (2010)

Investigating the role of Rts1 in DNA replication initiation [version 1; referees: 2 approved]
by: Ana B.A. Wallis, et al.
Published: (2018-03-01)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
by: Olotu, A, et al.
Published: (2013)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
by: Agnandji, S, et al.
Published: (2012)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
by: Olotu, A, et al.
Published: (2016)

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
by: Abdullah Nadeem, et al.
Published: (2023-01-01)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
by: Alan Brooks, et al.
Published: (2012-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
by: Arora N, et al.
Published: (2021-03-01)

Understanding the fine-scale heterogeneity and spatial drivers of malaria transmission in Kenya using model-based geostatistical methods
by: Donnie Mategula, et al.
Published: (2023-01-01)

Characterisation of tuberculosis mortality in informal settlements in Nairobi, Kenya: analysis of data between 2002 and 2016
by: Judy Gichuki, et al.
Published: (2021-07-01)

Minimum incidence of adult invasive pneumococcal disease in Blantyre, Malawi an urban african setting: a hospital based prospective cohort study.
by: Naor Bar-Zeev, et al.
Published: (2015-01-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
by: Seth Owusu-Agyei, et al.
Published: (2009-10-01)

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries
by: Christophe Sauboin, et al.
Published: (2019-12-01)

Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
Published: (2010-01-01)

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D).
by: Selidji T Agnandji, et al.
Published: (2011-04-01)

Human Melioidosis, Malawi, 2011
by: Thembi Katangwe, et al.
Published: (2013-06-01)

Perceptions and experiences of intravenous iron treatment for anaemia in pregnancy in Malawi: a formative qualitative study [version 4; peer review: 2 approved, 1 approved with reservations]
by: Ricardo Ataíde, et al.
Published: (2024-03-01)

Perceptions and experiences of intravenous iron treatment for anaemia in pregnancy in Malawi: a formative qualitative study [version 3; peer review: 2 approved, 1 approved with reservations]
by: Ricardo Ataíde, et al.
Published: (2023-07-01)

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
by: Galactionova, K, et al.
Published: (2017)